Wyost (denosumab 120 mg/1.7 ml)

pCPA File Number: 22681
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple Indications
Sponsor/Manufacturer:
Sandoz Canada Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: